Pancreatic Cancer Research

ResearcherUniversity Hospital ZurichActive in the last 2 years

Përparim Limani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4158-4666; OpenAlex author ID A5051415467. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Hypoxic Tumor Microenvironment Targeting: Opportunities and Challenges for Pancreatic Cancer Immunotherapy. Co-author DOI 10.3390/ijms27093873↗
  2. Hypoxia, a Targetable Culprit to Counter Pancreatic Cancer Resistance to Therapy. Co-author DOI 10.3390/cancers15041235↗
  3. [Pancreatic cancer- a curable disease]. Co-author DOI 10.1024/1661-8157/a001990↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Raefa Abou Khouzam · 2 shared papers, 2023–2026 · strength 0.51
  2. Salem Chouaı̈b · 2 shared papers, 2023–2026 · strength 0.51
  3. Pierre‐Alain Clavien · 2 shared papers, 2015–2023 · strength 0.25
  4. Michel Pierre Ducreux · 1 shared paper, 2023 · strength 0.19
  5. Michael B. Wallace · 1 shared paper, 2023 · strength 0.19
  6. Michelle Lucinda DeOliveira · 1 shared paper, 2015 · strength 0.06
  7. Panagiotis Samaras · 1 shared paper, 2015 · strength 0.06
  8. Mickaël Lesurtel · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.